Gilead Will License Solvadi to Generic Makers

  • Posted by
  • on September 15th, 2014

 

Gilead ($GILD) officially announced today that it would allow other drugmakers to produce and sell generic versions of its blockbuster Hep-C drug in exchange for royalty payments. Here’s a brief vid on it from The Street:

 

source:  Gilead Expands Access of Hepatitis C Drug in Developing Countries – The Street


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

blog comments powered by Disqus
Wall Street Bean Blog